In the first 3 months, metabolic function improves and you'll experience reduced cravings, improved eating habits and decreased calorie intakes From months 4 - 6, around 5% weight loss could occur, alongside better eating control, enhanced energy levels and improved sleep From months 6 - 12, around 9 - 20% of weight loss could occur, alongside reductions in blood pressure, blood sugar and cholesterol levels
GLP-1 medications for cardiovascular risks Some GLP-1 agonists are approved to lower the risk of heart attacks, strokes, and cardiovascular death, with the list of GLP-1s for this use continuing to grow
This makes it a convenient and lasting choice to support your overall well-being.
And that's how all these new generation medications work by reducing appetite, which leads to reducing caloric intake, which then leads to losing body weight
Peptides (2016) 77:217
SLC47A1 ) and 2-k (MATE2-k